We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Else Nutrition Holdings Inc (BABY) NPV

Sell:0.025 CAD Buy:0.03 CAD Change: No change
Market closed |  Prices as at close on 21 November 2024 | Switch to live prices |
Sell:0.025 CAD
Buy:0.03 CAD
Change: No change
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 21 November 2024 | Switch to live prices |
Sell:0.025 CAD
Buy:0.03 CAD
Change: No change
Market closed |  Prices as at close on 21 November 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Else Nutrition Holdings Inc is an Israel-based company active in field of food manufacturing. The Company focuses on research, development, manufacturing, marketing and sale of innovative plant-based food and nutrition products and also maintain feeding accessories products to infants and dried food snacks.

Contact details

Address:
6 Hanechoshet Street
TEL AVIV-YAFO
6971904
Israel
Telephone:
+1 (604) 6309795
Website:
https://elsenutrition.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
BABY
ISIN:
CA2902571041
Market cap:
5.05 million CAD
Shares in issue:
201.81 million
Sector:
Packaged Foods & Meats
Exchange:
Toronto Stock Exchange
Country:
Canada
Currency:
Canadian dollars
Indices:
n/a

Key personnel

  • Hamutal Yitzhak
    Chairman of the Board, Chief Executive Officer
  • Shay Shamir
    Chief Financial Officer, Corporate Secretary
  • Uriel Kesler
    Chief Operating Officer, Director
  • Michael Azar
    Chief Technology Officer
  • Reuben Halevi
    Vice President Sales Operations
  • Mike Glick
    U.S. General Manager, Vice President - North America
  • Simeon Saunders
    Vice President - Medical and Scientific Affairs

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.